当前位置: 首页 JCRQ1 期刊介绍(非官网)
Alzheimers & Dementia-translational Research & Clinical Interventions

Alzheimers & Dementia-translational Research & Clinical Interventions

SCIE

国际简称:ALZH DEMENT-TRCI  参考译名:阿尔茨海默氏症和痴呆症转化研究与临床干预

  • 中科院分区

    2区

  • CiteScore分区

    Q1

  • JCR分区

    Q1

基本信息:
ISSN:2352-8737
是否OA:未开放
是否预警:否
TOP期刊:是
出版信息:
出版地区:United States
出版商:Wiley-Blackwell
出版语言:English
研究方向:Multiple
评价信息:
影响因子:7.4
CiteScore指数:10.2
SJR指数:1.923
SNIP指数:1.574
发文数据:
Gold OA文章占比:99.64%
研究类文章占比:90.67%
年发文量:150
自引率:0.0208...
开源占比:0.6973
出版撤稿占比:
出版国人文章占比:0
OA被引用占比:
英文简介 期刊介绍 CiteScore数据 中科院SCI分区 JCR分区 发文数据 常见问题

英文简介Alzheimers & Dementia-translational Research & Clinical Interventions期刊介绍

Alzheimer's&Dementia: Translational Research&Clinical Interventions "is an international journal dedicated to Alzheimer's disease and other forms of dementia, published by Elsevier Press. This journal emphasizes translational research and clinical intervention measures, aiming to accelerate the transformation of research results from laboratory to clinical settings. The journal covers multiple fields including behavioral science, biochemistry, genetics, molecular biology, pharmacology, physiology, protein chemistry, neurology, neuropathology, psychiatry, geriatrics, neuropsychology, epidemiology, sociology, health service research, health economics, political science, and public policy.

The magazine places special emphasis on interdisciplinary research and the integration/translation of articles that cover the etiology, risk factors, early detection, disease modification interventions, prevention, and the application of new technologies in health services. The goal of the journal is to provide a platform for researchers, clinicians, and policy makers to share the latest research findings, promote a deeper understanding of Alzheimer's disease and other dementia, and develop effective treatment strategies.

期刊简介Alzheimers & Dementia-translational Research & Clinical Interventions期刊介绍

《Alzheimers & Dementia-translational Research & Clinical Interventions》是一本医学优秀杂志。致力于发表原创科学研究结果,并为医学各个领域的原创研究提供一个展示平台,以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述,从广泛的视角提供当前感兴趣的研究主题的新见解,或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单,目前已被权威数据库SCIE收录,得到了广泛的认可。

该期刊投稿重要关注点:

Cite Score数据(2026年6月最新版)Alzheimers & Dementia-translational Research & Clinical Interventions Cite Score数据

  • CiteScore:10.2
  • SJR:1.923
  • SNIP:1.574
学科类别 分区 排名 百分位
大类:Medicine 小类:Psychiatry and Mental Health Q1 36 / 580

93%

大类:Medicine 小类:Neurology (clinical) Q1 36 / 403

91%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础,针对的是前四年发表的论文的引文。CiteScore的意义在于,它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法,而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Alzheimers & Dementia-translational Research & Clinical Interventions 中科院分区

《新锐期刊分区表》(2026年3月发布) 综述期刊:否 Top期刊:否
大类学科 分区 小类学科 分区
医学 2区 CLINICAL NEUROLOGY 临床神经病学 NEUROSCIENCES 神经科学 2区 2区
期刊分区表(2025年3月升级版) 综述期刊:否 Top期刊:否
大类学科 分区 小类学科 分区
医学 2区 NEUROSCIENCES 神经科学 CLINICAL NEUROLOGY 临床神经病学 2区 3区

中科院分区表 是以客观数据为基础,运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据,得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次,类似于“优、良、及格”等。最开始,这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Alzheimers & Dementia-translational Research & Clinical Interventions JCR分区

2025-2026年最新版
按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CLINICAL NEUROLOGY ESCI Q1 21 / 296

93.1

学科:NEUROSCIENCES ESCI Q1 32 / 330

90.5

学科:CLINICAL NEUROLOGY ESCI Q1 27 / 296

91.05

学科:NEUROSCIENCES ESCI Q1 31 / 330

90.76

2023-2024年最新版
按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CLINICAL NEUROLOGY ESCI Q1 35 / 277

87.5

学科:NEUROSCIENCES ESCI Q1 54 / 310

82.7

学科:CLINICAL NEUROLOGY ESCI Q1 39 / 278

86.15

学科:NEUROSCIENCES ESCI Q1 51 / 310

83.71

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异,此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此,JCR将期刊按照学科门类和影响因子分为不同的分区,这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

本刊中国学者近年发表论文

  • 1、The multifaceted roles of the transcription factor SP1 in the pathogenesis of Alzheimer's disease: From molecular regulation to therapeutic target

    Author: Lv, Zhengxiang; Liu, Xiaodong; Huang, Qin; Liu, Haijun; Xu, Zucai; Xu, Ping

    Journal: ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS. 2026; Vol. 12, Issue 2, pp. -. DOI: 10.1002/trc2.70211

  • 2、A sex-specific hormone-bone-brain axis in Alzheimer's disease: Integrating Global Burden of Disease data and Mendelian randomization analysis to reveal the causal role of osteocalci

    Author: Zheng, Zhiyang; Ren, Yifan; Gao, Jingzhe; Chen, Jianglong; Yuan, Ke; Zhang, Zhongqiang; Wang, Zhigang; Lei, Xia; Zhang, Yafeng; Ai, Hao; Geng, Fang; Zhang, Ning; Xu, Hongdan

    Journal: ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS. 2026; Vol. 12, Issue 1, pp. -. DOI: 10.1002/trc2.70206

  • 3、Effects of multidomain intervention on cognitive function in older adults with cognitive impairment: A multicenter, four-arm, cluster randomized tria

    Author: Yin, Zhaoxue; Gao, Xin; Yang, Huan; Jie, Wan; Wang, Anqi; Wu, Jing

    Journal: ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS. 2026; Vol. 12, Issue 1, pp. -. DOI: 10.1002/trc2.70221

  • 4、Baseline characteristics from evoke and evoke plus : Two phase 3 randomized placebo-controlled trials of semaglutide in participants with early-stage symptomatic Alzheimer's diseas

    Author: Scheltens, Philip; Atri, Alireza; Feldman, Howard H.; Zetterberg, Henrik; Sano, Mary; Johannsen, Peter; Colombo, Teresa Leon; Bardtrum, Lars; Jeppesen, Rose; Hansen, Charlotte T.; Cummings, Jeffrey L

    Journal: ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS. 2026; Vol. 12, Issue 1, pp. -. DOI: 10.1002/trc2.70200

  • 5、APOE ε4-independent pathways predominate in the association between retinal nerve fiber layer thinning and 12-year incident dementi

    Author: Wang, Yuzhuo; Ma, Xiaoxi; Cen, Haoze; Wang, Jie; Wu, Jie; Ding, Ding; Xiao, Yiqin; Zhao, Qianhua

    Journal: ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS. 2025; Vol. 11, Issue 2, pp. -. DOI: 10.1002/trc2.70104

  • 6、The impact of estimated cardiorespiratory fitness on Alzheimer's disease biomarkers and their relationships with cognitive declin

    Author: Paulsen, Adam J.; Driscoll, Ira; Breidenbach, Brianne M.; Glittenberg, Matthew; Lose, Sarah R.; Ma, Yue; Sager, Mark A.; Carlsson, Cynthia M.; Gallagher, Catherine L.; Hermann, Bruce P.; Blennow, Kaj; Zetterberg, Henrik; Asthana, Sanjay; Johnson, Sterling C.; Betthauser, Tobey J.; Christian, Bradley T.; Cook, Dane B.; Okonkwo, Ozioma C

    Journal: ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS. 2025; Vol. 11, Issue 2, pp. -. DOI: 10.1002/trc2.70122

  • 7、Association of allostatic load with all-cause and cause-specific dementia: A prospective cohort stud

    Author: Gou, Yifan; Qi, Xin; Liu, Chen; Hui, Jingni; Liu, Ye; Kang, Meijuan; Zhou, Ruixue; Wang, Bingyi; Shi, Panxing; Zhang, Feng

    Journal: ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS. 2025; Vol. 11, Issue 2, pp. -. DOI: 10.1002/trc2.70108

  • 8、Clinical efficacy of anti-amyloid antibodies in apolipoprotein E ε4 homozygotes: A Bayesian reanalysis of lecanemab and donanemab phase 3 result

    Author: Teipel, Stefan; Tang, Yi; Khachaturian, Ara

    Journal: ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS. 2025; Vol. 11, Issue 2, pp. -. DOI: 10.1002/trc2.70083

投稿常见问题